These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17563269)

  • 21. [Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione].
    Masuda K; Terauchi Y
    Nihon Rinsho; 2010 May; 68(5):969-75. PubMed ID: 20446599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes.
    Henry RR
    Clin Ther; 2003; 25 Suppl B():B47-63. PubMed ID: 14553866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.
    Kahn SE; Lachin JM; Zinman B; Haffner SM; Aftring RP; Paul G; Kravitz BG; Herman WH; Viberti G; Holman RR;
    Diabetes; 2011 May; 60(5):1552-60. PubMed ID: 21415383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.
    Bailey CJ
    Diabetes Obes Metab; 2005 Nov; 7(6):675-91. PubMed ID: 16219011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial.
    Cai XL; Chen YL; Zhao JJ; Shan ZY; Qiu MC; Li CJ; Gu W; Tian HM; Yang HZ; Xue YM; Yang JK; Hong TP; Ji LN
    Chin Med J (Engl); 2015 May; 128(10):1279-87. PubMed ID: 25963345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.
    Silic A; Janez A; Tomazic J; Karner P; Vidmar L; Sharma P; Maticic M
    Croat Med J; 2007 Dec; 48(6):791-9. PubMed ID: 18074413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.
    Home PD; Pocock SJ; Beck-Nielsen H; Gomis R; Hanefeld M; Dargie H; Komajda M; Gubb J; Biswas N; Jones NP
    Diabetologia; 2005 Sep; 48(9):1726-35. PubMed ID: 16025252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
    Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
    Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone : a review of its use in type 2 diabetes mellitus.
    Deeks ED; Keam SJ
    Drugs; 2007; 67(18):2747-79. PubMed ID: 18062722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
    Viljanen AP; Virtanen KA; Järvisalo MJ; Hällsten K; Parkkola R; Rönnemaa T; Lönnqvist F; Iozzo P; Ferrannini E; Nuutila P
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6523-8. PubMed ID: 16189256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth.
    Holloway AC; Hettinga BP; Gerstein HC
    J Diabetes; 2011 Mar; 3(1):74-81. PubMed ID: 21040499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.
    Narasimhan S; Weinstock RS
    Mayo Clin Proc; 2014 Jun; 89(6):806-16. PubMed ID: 24702733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementary mode of action of rosiglitazone and metformin in a single tablet for the treatment of diabetes mellitus type 2.
    Petersen KU
    Arzneimittelforschung; 2004; 54(1):20-30. PubMed ID: 14979605
    [No Abstract]   [Full Text] [Related]  

  • 39. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.